Wales Dominic J, Keshavarz Meysam, Howe Carmel, Yeatman Eric
Hamlyn Centre, Institute of Global Health Innovation, Imperial College London, London SW7 2AZ, U.K.
Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom.
ACS Appl Polym Mater. 2022 Aug 12;4(8):5457-5470. doi: 10.1021/acsapm.2c00531. Epub 2022 Jul 7.
Herein, we present the first example of 3D printing with poly(octamethylene maleate (anhydride) citrate) (POMaC), a bio-adhesive material which has shown particular promise for implantable biomedical devices. The current methods to fabricate such devices made from POMaC are hindered by the imposed constraints of designing complex molds. We demonstrate the feasibility of exploiting additive manufacturing to 3D print structural functional materials consisting of POMaC. We present 3D printing of biomaterial copolymers consisting of mixtures of poly(ethylene glycol) diacrylate (PEGDA) and POMaC at different ratios. The required parameters were optimized, and characterization of the printing fidelity and physical properties was performed. We have also demonstrated that a range of mechanical properties can be achieved by tuning the POMaC/PEGDA ratio. The biocompatibility of the copolymers was ascertained via a cell viability assay. Such tunable 3D printed biomaterials consisting of POMaC and PEGDA will have significant potential application in the development of functional biomaterial tissue scaffolds and biomedical devices for the future of personalized medicine.
在此,我们展示了使用聚(马来酸(酐)柠檬酸辛二酯)(POMaC)进行3D打印的首个实例,POMaC是一种生物粘附材料,在可植入生物医学设备方面显示出特别的前景。目前由POMaC制造此类设备的方法受到设计复杂模具的限制。我们证明了利用增材制造来3D打印由POMaC组成的结构功能材料的可行性。我们展示了以不同比例的聚乙二醇二丙烯酸酯(PEGDA)和POMaC混合物组成的生物材料共聚物的3D打印。优化了所需参数,并对打印精度和物理性能进行了表征。我们还证明了通过调整POMaC/PEGDA比例可以实现一系列机械性能。通过细胞活力测定确定了共聚物的生物相容性。这种由POMaC和PEGDA组成的可调节3D打印生物材料在功能性生物材料组织支架和用于未来个性化医学的生物医学设备的开发中将具有巨大的潜在应用价值。